pdufa.bio
CalendarReadoutsDevicesDecisionsApprovals/yrTrial oddsLearnResearchMethodology
Home › Readouts › November 2026

November 2026 clinical-trial readouts

trial-readout estimates for November 2026, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.
← October 2026December 2026 →
31 readouts
ATOS · Nov 2026 (est.)
Z-Endoxifen — Breast Neoplasms
APGE · Nov 2026 (est.)
APG777 — Atopic Dermatitis
TLX · Nov 2026 (est.)
177Lu-TLX591 — Prostate Adenocarcinoma
ERAS · Nov 2026 (est.)
Naporafenib — Advanced or Metastatic Solid Tumors
GILD · Nov 2026 (est.)
Sacituzumab Govitecan — Esophageal Squamous Cell Carcinoma
IMUX · Nov 2026 (est.)
IMU-838 tablets — Multiple Sclerosis
IOVA · Nov 2026 (est.)
Lifileucel plus Pembrolizumab — Metastatic Melanoma
KPRX · Nov 2026 (est.)
KIO-104 — Macular Edema
ONC · Nov 2026 (est.)
BGB-11417 — Relapsed/Refractory Multiple Myeloma
ANL · Nov 2026 (est.)
Buparlisib & Paclitaxel — Advanced Solid Tumor
TRAW · Nov 2026 (est.)
rigosertib — Influenza
TYRA · Nov 2026 (est.)
TYRA-300 — Locally Advanced Urothelial Carcinoma
VIR · Nov 2026 (est.)
Bulevirtide — Viral Hepatitis
VXRT · Nov 2026 (est.)
VXA-COV2-3.3 — SARS-CoV2
ZURA · Nov 2026 (est.)
Tibulizumab — Hidradenitis Suppurativa (HS)
ELTX · Nov 2026 (est.)
ELI-002 7P — Pancreatic Ductal Adenocarcinoma
DRUG · Nov 2026 (est.)
BMB-101 — Prader-Willi Syndrome
CRDF · Nov 2026 (est.)
Onvansertib — Metastatic Colorectal Cancer
BHVN · Nov 2026 (est.)
BHV-7000 — Familial Erythromelalgia
BYSI · Nov 2026 (est.)
Docetaxel + Plinabulin — Multiple Myeloma
CGEM · Nov 2026 (est.)
CLN-081 — NHL
EVO · Nov 2026 (est.)
JST-018 — Antiviral Drug
PGEN · Nov 2026 (est.)
PRGN-2009 — Cervical Cancer
ACHV · Nov 2026 (est.)
Custirsen — Vaping Cessation
SKYE · Nov 2026 (est.)
SBI-100 Ophthalmic Emulsion, — Obesity
AURA · Nov 2026 (est.)
Bel-sar — Eye Cancer
BIOA · Nov 2026 (est.)
BGE-102 — Obesity and Cardiovascular Risk
PHAR · Nov 2026 (est.)
Leniolisib — APDS
QURE · Nov 2026 (est.)
AMT-260 — Mesial Temporal Lobe Epilepsy
RNAC · Nov 2026 (est.)
Decartes-08 — Myasthaenia Gravis
SNY · Nov 2026 (est.)
Rilzabrutinib — Immune Thrombocytopenia
Looking for an approval probability for these? We deliberately don't publish one — here's why, and what we show instead (verified history + base rates).